Literature DB >> 22334261

Light-emitting diodes at 830 and 850 nm inhibit melanin synthesis in vitro.

Jeong Mo Kim1, Nan-Hyung Kim, Yu Shun Tian, Ai Young Lee.   

Abstract

Treatment of hyperpigmentation remains a challenge. Because of the positive effects of low-energy Nd:YAG lasers on the treatment of melasma, it is suggested that laser-like light-emitting diodes (LEDs) can potentially ameliorate hyperpigmentation. We evaluated the effect of seven different LED wavelengths on melanogenesis. LED irradiation at 830 nm (dose-dependent, from 1 to 20 J/cm2) and 850 nm (1 J/cm2) significantly reduced melanin production and tyrosinase expression, not only in a normal human melanocyte monoculture both with and without forskolin stimulation but also in a three-dimensional multiple cell type culture. It reduced melanin content via inactivation of the apoptosis signal-regulating kinase and extracellular signal-regulated kinase 1/2 pathways. The level of phosphorylated cyclic AMP response element-binding protein was also decreased by LED irradiation. Moreover, LED irradiation reduced melanogenesis through decreased expression of tyrosinase family genes (tyrosinase-related protein-1 and 2, and microphthalmia-associated transcription factor). These results indicate that LEDs could potentially be used to treat melanin-overproducing skin conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22334261     DOI: 10.2340/00015555-1319

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  2 in total

1.  Dual Effect of Photobiomodulation on Melasma: Downregulation of Hyperpigmentation and Enhanced Solar Resistance-A Pilot Study.

Authors:  Daniel Barolet
Journal:  J Clin Aesthet Dermatol       Date:  2018-04-01

2.  Study on injection molding analysis of glasses-type wearable device for facial skin care.

Authors:  Mi Yeon Shin; Woo Suk Chong; Kyong Kim; Chang Ho Yu
Journal:  Technol Health Care       Date:  2020       Impact factor: 1.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.